Literature DB >> 20964521

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.

Joseph T Wu1, Edward S K Ma, Cheuk Kwong Lee, Daniel K W Chu, Po-Lai Ho, Angela L Shen, Andrew Ho, Ivan F N Hung, Steven Riley, Lai Ming Ho, Che Kit Lin, Thomas Tsang, Su-Vui Lo, Yu-Lung Lau, Gabriel M Leung, Benjamin J Cowling, J S Malik Peiris.   

Abstract

BACKGROUND: Serial cross-sectional data on antibody levels to the 2009 pandemic H1N1 influenza A virus from a population can be used to estimate the infection attack rates and immunity against future infection in the community.
METHODS: From April through December 2009, we obtained 12,217 serum specimens from blood donors (aged 16-59 years), 2520 specimens from hospital outpatients (aged 5-59 years), and 917 specimens from subjects involved in a community pediatric cohort study (aged 5-14 years). We estimated infection attack rates by comparing the proportions of specimens with antibody titers ≥ 1:40 by viral microneutralization before and after the first wave of the pandemic. Estimates were validated using paired serum samples from 324 individuals that spanned the first wave. Combining these estimates with epidemiologic surveillance data, we calculated the proportion of infections that led to hospitalization, admission to the intensive care unit (ICU), and death.
RESULTS: We found that 3.3% and 14% of persons aged 5-59 years had antibody titers ≥ 1:40 before and after the first wave, respectively. The overall attack rate was 10.7%, with age stratification as follows: 43.4% in persons aged 5-14 years, 15.8% in persons aged 15-19 years, 11.8% in persons aged 20-29 years, and 4%-4.6% in persons aged 30-59 years. Case-hospitalization rates were 0.47%-0.87% among persons aged 5-59 years. Case-ICU rates were 7.9 cases per 100,000 infections in persons aged 5-14 years and 75 cases per 100,000 infections in persons aged 50-59 years, respectively. Case-fatality rates were 0.4 cases per 100,000 infections in persons aged 5-14 years and 26.5 cases per 100,000 infections in persons aged 50-59 years, respectively.
CONCLUSIONS: Almost half of all school-aged children in Hong Kong were infected during the first wave. Compared with school children aged 5-14 years, older adults aged 50-59 years had 9.5 and 66 times higher risks of ICU admission and death if infected, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20964521      PMCID: PMC3034199          DOI: 10.1086/656740

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Influenza-associated mortality in Hong Kong.

Authors:  Chit-Ming Wong; King-Pan Chan; Anthony Johnson Hedley; J S Malik Peiris
Journal:  Clin Infect Dis       Date:  2004-11-10       Impact factor: 9.079

2.  The ecology of health care in Hong Kong.

Authors:  Gabriel M Leung; Irene O L Wong; Wai-Sum Chan; Sarah Choi; Su-Vui Lo
Journal:  Soc Sci Med       Date:  2005-02-12       Impact factor: 4.634

3.  Optimizing influenza vaccine distribution.

Authors:  Jan Medlock; Alison P Galvani
Journal:  Science       Date:  2009-08-20       Impact factor: 47.728

4.  Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009.

Authors:  M G Baker; N Wilson; Q S Huang; S Paine; L Lopez; D Bandaranayake; M Tobias; K Mason; G F Mackereth; M Jacobs; C Thornley; S Roberts; C McArthur
Journal:  Euro Surveill       Date:  2009-08-27

5.  Assessing the severity of the novel influenza A/H1N1 pandemic.

Authors:  Tini Garske; Judith Legrand; Christl A Donnelly; Helen Ward; Simon Cauchemez; Christophe Fraser; Neil M Ferguson; Azra C Ghani
Journal:  BMJ       Date:  2009-07-14

6.  Managing and reducing uncertainty in an emerging influenza pandemic.

Authors:  Marc Lipsitch; Steven Riley; Simon Cauchemez; Azra C Ghani; Neil M Ferguson
Journal:  N Engl J Med       Date:  2009-05-27       Impact factor: 91.245

7.  Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis.

Authors:  Santiago Echevarría-Zuno; Juan Manuel Mejía-Aranguré; Alvaro J Mar-Obeso; Concepción Grajales-Muñiz; Eduardo Robles-Pérez; Margot González-León; Manuel Carlos Ortega-Alvarez; Cesar Gonzalez-Bonilla; Ramón Alberto Rascón-Pacheco; Víctor Hugo Borja-Aburto
Journal:  Lancet       Date:  2009-11-11       Impact factor: 79.321

8.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

9.  Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.

Authors:  Nicole E Basta; Dennis L Chao; M Elizabeth Halloran; Laura Matrajt; Ira M Longini
Journal:  Am J Epidemiol       Date:  2009-08-13       Impact factor: 4.897

10.  Pandemic potential of a strain of influenza A (H1N1): early findings.

Authors:  Christophe Fraser; Christl A Donnelly; Simon Cauchemez; William P Hanage; Maria D Van Kerkhove; T Déirdre Hollingsworth; Jamie Griffin; Rebecca F Baggaley; Helen E Jenkins; Emily J Lyons; Thibaut Jombart; Wes R Hinsley; Nicholas C Grassly; Francois Balloux; Azra C Ghani; Neil M Ferguson; Andrew Rambaut; Oliver G Pybus; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ietza Bojorquez Chapela; Ethel Palacios Zavala; Dulce Ma Espejo Guevara; Francesco Checchi; Erika Garcia; Stephane Hugonnet; Cathy Roth
Journal:  Science       Date:  2009-05-11       Impact factor: 47.728

View more
  98 in total

1.  Antibody prevalence to the 2009 pandemic influenza A (H1N1) virus in Germany: geographically variable immunity in winter 2010/2011.

Authors:  Anne Hackenberg; Gökhan Arman-Kalcek; Jens Hiller; Gülsah Gabriel
Journal:  Med Microbiol Immunol       Date:  2012-06-10       Impact factor: 3.402

2.  Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva.

Authors:  Renee W Y Chan; Sara S R Kang; Hui-Ling Yen; Alan C L Li; Lynsia L S Tang; Wendy C L Yu; Kit M Yuen; Icarus W W Chan; Diana D Y Wong; Wico W Lai; Dora L W Kwong; Alan D L Sihoe; Leo L M Poon; Yi Guan; John M Nicholls; J S Malik Peiris; Michael C W Chan
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Toward effective vaccine deployment: a systematic study.

Authors:  Jiming Liu; Shang Xia
Journal:  J Med Syst       Date:  2011-05-24       Impact factor: 4.460

4.  Modelling the propagation of social response during a disease outbreak.

Authors:  Shannon M Fast; Marta C González; James M Wilson; Natasha Markuzon
Journal:  J R Soc Interface       Date:  2015-03-06       Impact factor: 4.118

Review 5.  Seroprevalence to influenza A(H1N1) 2009 virus--where are we?

Authors:  Eeva Broberg; Angus Nicoll; Andrew Amato-Gauci
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

6.  Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.

Authors:  Kin On Kwok; Steven Riley; Ranawaka A P M Perera; Vivian W I Wei; Peng Wu; Lan Wei; Daniel K W Chu; Ian G Barr; J S Malik Peiris; Benjamin J Cowling
Journal:  BMC Infect Dis       Date:  2017-05-11       Impact factor: 3.090

Review 7.  Case fatality risk of influenza A (H1N1pdm09): a systematic review.

Authors:  Jessica Y Wong; Heath Kelly; Dennis K M Ip; Joseph T Wu; Gabriel M Leung; Benjamin J Cowling
Journal:  Epidemiology       Date:  2013-11       Impact factor: 4.822

8.  Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong.

Authors:  Jessica Y Wong; Peng Wu; Hiroshi Nishiura; Edward Goldstein; Eric H Y Lau; Lin Yang; S K Chuang; Thomas Tsang; J S Malik Peiris; Joseph T Wu; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

9.  Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.

Authors:  Marc Baguelin; Katja Hoschler; Elaine Stanford; Pauline Waight; Pia Hardelid; Nick Andrews; Elizabeth Miller
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

10.  Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.

Authors:  Michael C W Chan; Denise I T Kuok; Connie Y H Leung; Kenrie P Y Hui; Sophie A Valkenburg; Eric H Y Lau; John M Nicholls; Xiaohui Fang; Yi Guan; Jae W Lee; Renee W Y Chan; Robert G Webster; Michael A Matthay; J S Malik Peiris
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.